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A B S T R A C T
Background: In 1998, we set up nurse-led epilepsy clinics in ﬁve rural health centres around Gondar in
northern Ethiopia. Despite good treatment outcomes, two years after registration only 40% of patients
were still under follow-up.
Aim: The purpose of this study was to examine the causes of default and factors that might improve
adherence to follow-up.
Method: The study was carried out at one of the ﬁve health centres. Patients who had defaulted from
follow-up were identiﬁed from the clinic register. Trained enumerators visited the patients’ villages and
administered a questionnaire to the patients, or relatives if the patient was not available.
Results: 113 patients were traced. 28 (25%) had died and 21 (19%) had moved from the area. Of the
remaining 64 patients, seven were accessing treatment from another source and 13 were in remission off
treatment. 44 patients were still experiencing seizures and were on no treatment or had reverted to
traditional remedies. The main reason given for default, in 44% of the patients, was difﬁculty in travelling
to the health centre. 12% claimed that they preferred traditional remedies and 9% felt that they had not
been improved by medical treatment.
Conclusion: Despite decentralisation of care to rural health centres, the most common reason for default
was the distance to travel to the health centre. Further decentralisation of care to a community level
coupled with improved education may reduce default from follow-up.
 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Epilepsy is an important cause of disability, contributing 7
million disability adjusted life years to the global burden of
disease.1 This burden is particularly evident in less developed
countries where epilepsy often remains untreated.
Ethiopia is one of the least developed countries in the world. It
has a population of about 70 million, 85% of which lives in rural
areas. Epilepsy is themost common cause of neurological disability
in Ethiopia. It affects an estimated 5.2 per 1000 of the population,2
but only 2–13% of people with epilepsy living in rural areas receive
medical treatment.3,4,5 Causes of this ‘treatment gap’ include
inaccessibility of medical services, unavailability of antiepileptic
drugs, lack of awareness of medical treatment and cultural factors.* Corresponding author. Tel.: +44 2380 794793; fax: +44 2380 794148.
E-mail address: martin.prevett@btinternet.com (M. Prevett).
1059-1311/$ – see front matter  2008 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2008.07.002In April 1998, we set up nurse-led epilepsy clinics in ﬁve rural
health centres around Gondar in northern Ethiopia.5 A similar
programme was also established in four health centres around
Jimma in south west Ethiopia.6 Existing healthcare infrastructure
was used and the clinics were integrated with the routine services
of the heath centres with few additional resources.More than 5000
patients have now been registered across the health centres in
Gondar and Jimma.
In 2001, we reviewed the case records of patients registered at
the health centres linked to Gondar.7 Of those still under follow-up
two years after registration, 48% had been seizure free for one year
and another 34% had experienced a >90% reduction in seizure
frequency. Despite these good treatment outcomes, default from
follow-up was a major problem. At two health centres 73% were
still attending clinic two years after registration, but overall 60%
had defaulted from follow-up by two years. Default has also been a
signiﬁcant problem in Jimma,where 40% of patientswere lost from
follow-up.6 Similar default rates have been reported fromZaria and
Ibadan in Nigeria.8,9vier Ltd. All rights reserved.
Table 1
Outcome of patients who defaulted from follow-up
Outcome Number (%) of patients (n = 113)
Dead 28 (25%)
Moved 21 (19%)
In remission 16 (14%)
Ongoing seizures 48 (42%)
Table 2
Reasons given by patients for defaulting from follow-up
Main reason for
default (%) (n = 76)
% reporting as contributory
reason for default (n = 76)
Too far to travel 33 64
Unable to travel because
of epilepsy
4 26
Cost of travel 4 20
Lack of carer to accompany
patient
3 5
Traditional remedies preferred 12 51
No improvement with
treatment
9 28
Seizures much improved 8 16
Cost of treatment 3 11
Adverse effects of treatment 4 4
Dissatisfaction with the
clinic service
5 7
Seizures returned when
treatment ﬁnished
1 1
Did not understand the need
for follow-up
1 3
Other 13 24
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patients who defaulted from follow-up did so within two years of
registration and thereafter default was rare. Analysis of the health
centre records in Gondar suggested that treatment failure and
adverse effects were not the major determinants of default and
majority of patients were seizure free without signiﬁcant adverse
effects at the point of default. Unreliability of drug supplies and the
cost of treatment were suggested as potential causes of default in
Ibadan,9 but this is speculative and there are no reported studies in
which patients who have defaulted from follow-up have been
traced and the causes of default investigated.
The objective of this study was to trace patients who had
defaulted from follow-up to investigate the causes of default and
factors that might improve adherence to follow-up.
Methods
We conducted the study in the district surrounding Dabat
health centre, one of the ﬁve rural health centres with nurse-led
epilepsy clinics which are part of the Gondar non-communicable
disease project. We chose this health centre because the clinic had
a high default rate and because the district includes an area under
continual health surveillance by trained enumerators whichwould
facilitate the tracing of patients.
Dabat health centre is 75 km north of Gondar town. It serves a
population of approximately 200,000, spread across highland and
lowland areas, and is staffed by health ofﬁcers and nurses. The
nurse-led epilepsy clinic was established in April 1998 and 292
patients had been registered and started on treatment with
phenobarbital by May 2002.
We performed the study between May and August 2005. We
arbitrarily deﬁned default from follow-up as missing three
consecutive visits or not attending for 6 months. We examined
the clinic records and identiﬁed 165 patients who satisﬁed the
criteria for default. We recorded the patient’s personal details,
duration of follow-up, and seizure frequency prior to default.
Anticipating the likely difﬁculties in tracing patients living in
remote areas and with constraints on time, we decided to aim for a
sample size of 100 patients. We selected patients living in the area
under continual health surveillance and in surrounding villages.
We devised a questionnaire, which included information on
demographics, seizure control, treatment and reasons for default.
Patients were asked to select up to three reasons for default from a
list of options and then rank them. The enumerators, already
experienced in data collection and in tracing defaulters from a
similar study in rheumatic heart disease,10 were given two days
speciﬁc training on the questionnaire and the questionnaire was
ﬁeld tested before use.
Tracing of defaulters was attempted through visits by the
enumerators to the patients’ villages. Mules were used for less
accessible areas and village guides were hired to help locate
individual households. After obtaining informed consent, the
questionnaires were administered to the patient or their legal
guardian. If the patient had died, the questionnaire was completed
by a member of the family. Surviving defaulters were advised of
the date when the next epilepsy clinic would be held at the health
centre and were encouraged to attend.
The demographic component of the questionnaire, which
included education andmeasures of wealth, was also administered
to 72 consecutive patients under regular follow-up in the epilepsy
clinic at Dabat health centre.
Data were analysed using SPSS 10. Descriptive analyses, t test
and Chi Square test were used.
The study was approved and given ethical clearance by the
research and publication ofﬁce of the University of Gondar.Results
113 patients who had defaulted from follow-up were traced
(Table 1). Their median age was 24 years (range 7–75). 6%
defaulted after the ﬁrst clinic attendance. The median duration of
follow-up prior to default was 10 months (0–75). 52% had not
experienced any seizures for 2 months before their last
attendance.
28 (25%) had died and 21 (19%) had moved from the area.
Eleven patients died whilst under follow-up and 17 died after
defaulting from follow-up. The majority of the deaths (64%) were
related to epilepsy and due to injury sustained during seizures,
status epilepticus or sudden unexpected death in epilepsy.
Of the remaining 64 patients, seven were still on treatment
(ﬁve, although not attending the epilepsy clinic, were obtaining
treatment from the health centre and two were obtaining
treatment from other sources). 13 were in remission without
treatment. 44 patients were still experiencing seizures and were
not on treatment or had reverted to using traditional remedies. Of
these, 34% were experiencing one or more seizures per week, 34%
between one and three seizures per month and 32% less than one
seizure per month.
After exclusion of the patients who had died whilst under
follow-up, moved from the area or were still obtaining treatment
from the health centre, we examined the reasons given for default
(n = 76). The most common reason given for default was the
distance to travel to the health centre (Table 2) and this was cited
as the most important reason by 33%. When additional factors,
such as the cost of travel, inability to travel because of the epilepsy
and lack of a carer to accompany the patient were also taken into
account, difﬁculty in travelling to the clinic was the most
important reason for default in 44%. Preference for traditional
treatment was given as the main reason for default by 12%, but it
was a contributory factor in 51%. For 9%, the main reason for
Table 3
Education and measures of wealth in patients who defaulted from follow-up and
those still under follow-up
Defaulters
(n = 76)
Patients under
follow-up (n = 72)
Literate 46% 38%
Secondary education 5.3% 14%
Income other than farming 6.6% 8.4%
Iron roof 55% 51%
Mean number of people per room (S.D.) 4.9 (2.0) 5.0 (2.4)
Protected water supply 59% 63%
Sanitation (other than open pit/ﬁeld) 0.0% 0.0%
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contributory factor in 28%. As a group, however, 62% were seizure
free at their last clinic attendance compared with only 22% at the
time of the study (p < 0.01). Only 3% gave the cost of medication as
a reason for default and 4% gave the adverse effects of medication.
The mean [S.D.] time for patients who had defaulted from
follow-up to travel to the clinic was signiﬁcantly longer than for
patients still under regular follow-up (6.75 (5.12) h comparedwith
4.93 (5.56) h, p < 0.05). 72% relied on walking or mule to travel to
the clinic, and only 22% had access to public transport for all or part
of their journey. 25% were travelling for 10 h to reach the clinic
and so had to stay overnight before making the return journey.
There were no signiﬁcant differences in measures of education
and wealth between the patients who had defaulted from follow-
up and those still under regular follow-up (Table 3).
Discussion
We found a high mortality rate amongst patients who had
defaulted from follow-up and greater than expected migration
from the area. Themajority of surviving patients were no longer on
medical treatment and were experiencing frequent seizures.
Despite decentralisation of care to rural health centres, the main
reason given for default was difﬁculty travelling to the health
centre. Although 9% of the patients who defaulted from follow-up
reported lack of improvement with medical treatment as the main
reason for default and 12% a preference for traditional remedies,
they were much more likely to have been seizure free when they
were attending the clinic and it is possible that some of these
patients had not appreciated the need for long term treatment.
We did not attempt to trace all those who had defaulted from
follow-up at the health centre because tracing patients in rural
areas is very time consuming, but 113 from a possible 165 patients
were included in the study and we believe that this is likely to be a
representative sample. For those patients who had died, the likely
cause of death was established by interviewing the patient’s
family. Conﬁrmation of the cause of death was not possible
because there were no medical records or post-mortem data and
the ﬁndings should be interpreted with caution. The reasons given
for default represent the subjective views of the patients and
under-reporting of some factors and over-reporting of others
cannot be excluded.
To our knowledge, no other studies have speciﬁcally investi-
gated the causes of default from follow-up in people with epilepsy
in sub-Saharan Africa. In a report on default and non-compliance in
Zaria, Nigeria, 18 out of 45 patients (40%) with epilepsy defaulted
over a 30-month-period,8 but the fate of the patients and the
reasons for default were not established. The reasons for failure to
complete 12 months follow-up were documented in a treatment
study in 302 patients in Kenya.11 Fifty three patients (18%) did not
complete follow-up. Of these, 11% died, 25% moved from the study
area and 25% withdrew because of adverse effects. 32% did notcomply with treatment or refused further treatment, but the
reasons for this were not given. The short follow-up period and
relatively low rate of withdrawal from treatment may account for
the lower proportion of deaths and the higher proportion of
withdrawals due to adverse effects compared with our patients.
There are relatively few other data on mortality in people with
epilepsy in sub-Saharan Africa. Tekle-Haimanot reported an
annual crude death rate of 3.16% in 316 patients with epilepsy
living in rural central Ethiopia, twice the mortality rate in people
without epilepsy.4 In a cohort of 128 people with epilepsy in
Cameroon, most of whom were not receiving regular treatment,
29% died over a 10-year-period compared with 5% in age-matched
controls.12 This is comparable to the 25%mortality over a period of
7 years observed in our patients, who had defaulted from follow-
up. In a follow-up study performed in Tanzania, after 30 years, 67%
of 164 patients were known to have died and another 11% were
unaccounted for.13 Mortality was highest when treatment was
discontinued or taken irregularly, but was increased even in
patients receiving regular treatment. Eleven of the 28 deaths in our
patients occurred whilst they were under regular follow-up, but it
is not known whether these patients were adhering to treatment
when they died. There remains concern that the risks of abrupt
discontinuation or irregular treatment with phenobarbital are
greater than with other antiepileptic drugs. The majority of the
deaths in our patients, and those in the studies from Cameroon and
Tanzania, appeared to be seizure related, and measures to reduce
default from follow-up and improve adherence to treatment may
reduce mortality.
The incidence of epilepsy in less developed countries tends to
be higher than in industrialised countries despite similar
prevalence rates.14 This discrepancy is more likely to be explained
by a higher mortality amongst patients with epilepsy in less
developed countries than a higher rate of spontaneous remission.
Nevertheless, it would be expected that a proportion of patients
who had defaulted from follow-up and discontinued treatment
would remain in remission. A study performed in theUK found that
60% of patients who had been seizure free for two years on
treatment remained in remission after drug withdrawal,15 but
there are no equivalent data from sub-Saharan Africa. Themajority
of our patients had been taking treatment for less than one year
before they defaulted from follow-up, but 12% were in remission
without treatment.
The World Health Organisation advocates the use of primary
health care in less developed countries to improve access to
treatment of chronic diseases, such as epilepsy.16 In Ethiopia, rural
health centres, run by nurses and health ofﬁcers, are the focus of
primary health care. Although we have decentralised epilepsy
clinics for our patients to rural health centres nearer their homes,
the most common reason given for default from follow-up was
difﬁculty in travelling to the health centre. The mean time for a
return journey was >10 h and it is not surprising that a proportion
of patientswas not prepared tomake such a long journey regularly.
Distance and the cost of travel were not the only problems in
getting to the health centre; often patientswith epilepsywould not
be able to safely undertake a long journey unaccompanied and,
unless a family member or friend could be released from domestic
or farming duties, theywould not be able to attend clinic. Difﬁculty
in travelling to the clinic may also be a factor inﬂuencing ﬁrst
attendance; based on a prevalence of 5.2/1000, the total number of
patients registered with epilepsy represents less than one third of
the expected number of cases within the catchment area of the
health centre.
Our ﬁndings would suggest that delivery of care closer to the
patients’ homes would have the greatest potential to reduce
default from follow-up. Community health workers and commu-
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effective in the management of some infectious diseases in sub-
Saharan Africa17 and this could be used as a model for the
treatment of epilepsy. There is one report of this approach being
used successfully in the treatment of epilepsy in west Uganda.18
Patients who had defaulted from follow-up frequently
expressed a preference for traditional treatments even though
they were much less likely to be seizure free on traditional
treatment. It is recognised that patients are sometimes reluctant to
admit that they consult traditional healers and it is possible that
preference for traditional treatment was under-reported. A study
performed in a rural area of central Ethiopia found that 17% of the
community believed that epilepsy could be contagious or result
from evil spirits.19 Although the difﬁculties in travelling to the
health centre could have inﬂuenced the patients’ view of medical
treatment, the apparent preference of some patients for traditional
treatment may have cultural origins and in part reﬂect the
inﬂuence of the patients’ families and community. The health
centre nurses provide information verbally to patients and carers
attending the health centre, but improving education about
epilepsy and its treatment represents a further opportunity to
reduce default and improve adherence to treatment.
Adverse effects of treatment did not appear to be an important
cause of default in our patients. This ﬁnding is in keeping with
other studies in less developed countries which have shown low
rates of withdrawal from phenobarbital due to adverse effects. In
the randomised study of 302 adults and children with epilepsy
performed in Kenya, only 3.3% of patients on phenobarbital
withdrew treatment because of adverse effects (compared with
5.3% on carbamazepine).11 In a randomised study of 91 children in
Bangladesh, there was no signiﬁcant difference in behavioural
adverse effects between phenobarbital and carbamazepine, and
there were no withdrawals from phenobarbital during the 12
month follow-up period.20
In line with health centre policy, patients who are unable to
afford the cost of drugs and have the appropriate paperswere given
treatment without charge. It is, therefore, not surprising that the
cost of drugs was rarely given as a reason for default from follow-
up. Even for those patients having to pay for their treatment the
cost of phenobarbital is low (approximately 3 USD per year).
Socioeconomic status did not appear to be signiﬁcant factor
inﬂuencing default. Interestingly we have previously found that
although patients receiving treatment perceive beneﬁts in
measures of social, physical, natural and human capital, access
to treatment did not inﬂuence income (unpublished).
In conclusion, our ﬁndings suggest that treatment of epilepsy in
rural Ethiopia needs to be decentralised beyond the health centre
and what is traditionally viewed as primary care to a community
level. Embedding treatment in the community is likely to facilitate
the process of educating patients and their communities. Further
decentralisation of care coupled with improved education may
reduce default from follow-up, improve adherence to treatment
and reduce mortality. Our ﬁndings are likely to be relevant to the
management of epilepsy and other chronic non-communicablediseases in rural areas of other less developed countries with
similar primary care infrastructure. As anti-retroviral treatment
becomes more widely available in Ethiopia and other countries in
sub-Saharan Africa, the ﬁndingsmay also be relevant to the chronic
care of patients with HIV infection.
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